Fagron NV News - 4A5

Fagron shareholders approve all voting items at AGM and EGM

Fagron shareholders approve all voting items at AGM and EGM Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 13 May 2024...

Fagron publishes agenda for 2024 annual shareholders meeting and extraordinary general meeting

Fagron publishes agenda for 2024 annual shareholders meeting and extraordinary general meeting Regulated information Nazareth...

Record revenue of €209 million in first quarter reflecting 15% topline growth

Record revenue of €209 million in first quarter reflecting 15% topline growth Regulated information - inside informationNazareth...

Disclosure notification from Mawer Investment Management Ltd.

Disclosure notification from Mawer Investment Management Ltd. Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 19 March...

Fagron publishes annual report 2023

Fagron publishes annual report 2023 Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 14 March 2024 – 6:30 PM CET Fagron...

Fagron delivers strong performance with 12% topline growth and 14% increase in REBITDA for FY 2023

Fagron delivers strong performance with 12% topline growth and 14% increase in REBITDA for FY 2023 Regulated information – inside...

Disclosure notification from AOC Pharma S.à r.l. – passing 10% threshold

Disclosure notification from AOC Pharma S.à r.l. – passing 10% threshold Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands...

Disclosure of notification received from BNP Paribas Asset Management SA

Disclosure of notification received from BNP Paribas Asset Management SA Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands...

Disclosure of notification received from BNP Paribas Asset Management SA

Disclosure of notification received from BNP Paribas Asset Management SA Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands...

Continued strong third quarter performance with 11% topline growth to €191 million

Continued strong third quarter performance with 11% topline growth to €191 million Regulated information - inside informationNazareth...

Fagron completes share buy-back program

Fagron completes share buy-back program Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 19 September 2023 – 6PM CET...

Progress share buy-back program Fagron

Progress share buy-back program Fagron Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 15 September 2023 – 6PM CET...

Progress share buy-back program Fagron

Progress share buy-back program Fagron Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 8 September 2023 – 6PM CET...

Progress share buy-back program Fagron

Progress share buy-back program Fagron Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 1 September 2023 – 6PM CET...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Fagron NV (4A5)

Empower your portfolio: Real-time discussions and actionable trading ideas.

4A5 News

Fagron shareholders approve all voting items at AGM and EGM

Fagron publishes agenda for 2024 annual shareholders meeting and extraordinary general meeting

Record revenue of €209 million in first quarter reflecting 15% topline growth

Disclosure notification from Mawer Investment Management Ltd.

Fagron publishes annual report 2023

Fagron delivers strong performance with 12% topline growth and 14% increase in REBITDA for FY 2023

Disclosure notification from AOC Pharma S.à r.l. – passing 10% threshold

Disclosure of notification received from BNP Paribas Asset Management SA

Disclosure of notification received from BNP Paribas Asset Management SA

Continued strong third quarter performance with 11% topline growth to €191 million

Fagron completes share buy-back program

Progress share buy-back program Fagron

Progress share buy-back program Fagron

Progress share buy-back program Fagron

4A5 Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Fagron NV (4A5) News

Fagron NV (4A5)

Empower your portfolio: Real-time discussions and actionable trading ideas.

4A5 News

Fagron shareholders approve all voting items at AGM and EGM

Fagron publishes agenda for 2024 annual shareholders meeting and extraordinary general meeting

Record revenue of €209 million in first quarter reflecting 15% topline growth

Disclosure notification from Mawer Investment Management Ltd.

Fagron publishes annual report 2023

Fagron delivers strong performance with 12% topline growth and 14% increase in REBITDA for FY 2023

Disclosure notification from AOC Pharma S.à r.l. – passing 10% threshold

Disclosure of notification received from BNP Paribas Asset Management SA

Disclosure of notification received from BNP Paribas Asset Management SA

Continued strong third quarter performance with 11% topline growth to €191 million

Fagron completes share buy-back program

Progress share buy-back program Fagron

Progress share buy-back program Fagron

Progress share buy-back program Fagron

4A5 Discussion

Your Recent History